Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONWARD: AD04 (Ondansetron) in Alcohol Use Disorder
NCT04101227Phase 3Completed
- Sponsor
- Adial Pharmaceuticals, Inc.
- Start
- Feb 2020
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of ondansetron in alcohol use disorder (AUD), sponsored by Adial Pharmaceuticals, Inc.. Started Feb 2020; status: completed.
02
Drugs
ondansetron
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT04101227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04101227.